TWO SIGMA ADVISERS, LP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$197,732
+26.9%
173,449
+1.8%
0.00%
Q2 2023$155,869
+27.4%
170,349
-22.0%
0.00%
Q1 2023$122,363
-2.3%
218,349
+0.6%
0.00%
Q4 2022$125,295
+84.3%
217,149
+0.6%
0.00%
Q3 2022$68,000
-20.0%
215,949
-10.5%
0.00%
Q2 2022$85,000
-65.2%
241,349
-28.9%
0.00%
-100.0%
Q1 2022$244,000
-73.0%
339,449
-15.3%
0.00%
-50.0%
Q4 2021$905,000
-13.4%
400,649
+10.4%
0.00%
-33.3%
Q3 2021$1,045,000
-23.3%
362,892
+1.0%
0.00%
-25.0%
Q2 2021$1,362,000
-58.5%
359,392
-62.9%
0.00%
-55.6%
Q1 2021$3,281,000
+230.4%
969,145
+173.4%
0.01%
+200.0%
Q4 2020$993,000
+1.3%
354,528
-9.2%
0.00%0.0%
Q3 2020$980,000
-62.5%
390,596
+102.8%
0.00%
-62.5%
Q2 2020$2,616,000
+1151.7%
192,601
+597.7%
0.01%
+700.0%
Q1 2020$209,000
-56.7%
27,606
-43.0%
0.00%0.0%
Q2 2018$483,000
-38.7%
48,400
-41.5%
0.00%
-50.0%
Q1 2018$788,000
-37.2%
82,700
-1.9%
0.00%
-33.3%
Q4 2017$1,254,000
-18.8%
84,300
+7.4%
0.00%
-25.0%
Q3 2017$1,544,000
+308.5%
78,500
+198.5%
0.00%
+300.0%
Q2 2017$378,00026,3000.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Novo Holdings A/S 3,100,000$15,004,0002.10%
DAFNA Capital Management LLC 830,538$4,020,0001.51%
Baupost Group 24,471,453$118,442,0001.07%
Nantahala Capital Management 5,789,561$28,021,0000.86%
Old West Investment Management, LLC 367,870$1,780,0000.84%
Abrams Capital Management 5,656,462$27,377,0000.74%
Sofinnova Investments, Inc. 848,356$4,106,0000.38%
Stanley-Laman Group, Ltd. 312,609$1,513,0000.36%
Nantahala Capital Management 2,000,000$9,680,0000.30%
RICE HALL JAMES & ASSOCIATES, LLC 1,494,070$7,231,0000.24%
View complete list of AKEBIA THERAPEUTICS INC shareholders